Table 1.
Hormone-Related | |
Promotion of fluid retention | |
Increase in cardiovascular disease risk | |
Precipitation or worsening of sleep apnea | |
Gynecomastia | |
Polycythemia | |
Fluctuations in mood | |
Increased rate of development of benign or malignant prostate disease | |
Non-Hormone-Related | |
Preparation | Effect |
Testosterone undecanoate | Gastrointestinal bloating and irritation |
Injectable esters | Pain at sight of injection |
Implantable pellets | Pain or infection at site; extravasation of pellet |
Scrotal patch | Local site irritation |
Nonscrotal patch | Local site skin irritation, sometimes significant |
Transdermal gels | Occasional mild skin irritation |
Reprinted with permission from Tenover 13